658 related articles for article (PubMed ID: 29871515)
1. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of Human Neural Stem Cells in a Parkinsonian Model Exerts Neuroprotection via Regulation of the Host Microenvironment.
Zuo FX; Bao XJ; Sun XC; Wu J; Bai QR; Chen G; Li XY; Zhou QY; Yang YF; Shen Q; Wang RZ
Int J Mol Sci; 2015 Nov; 16(11):26473-92. PubMed ID: 26556344
[TBL] [Abstract][Full Text] [Related]
3. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
[TBL] [Abstract][Full Text] [Related]
4. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Singh S; Mishra A; Shukla S
Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model.
Tentillier N; Etzerodt A; Olesen MN; Rizalar FS; Jacobsen J; Bender D; Moestrup SK; Romero-Ramos M
J Neurosci; 2016 Sep; 36(36):9375-90. PubMed ID: 27605613
[TBL] [Abstract][Full Text] [Related]
6. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
Ramos-Moreno T; Castillo CG; Martínez-Serrano A
Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
[TBL] [Abstract][Full Text] [Related]
7. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.
Yan M; Sun M; Zhou Y; Wang W; He Z; Tang D; Lu S; Wang X; Li S; Wang W; Li H
PLoS One; 2013; 8(5):e64000. PubMed ID: 23724014
[TBL] [Abstract][Full Text] [Related]
8. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
[TBL] [Abstract][Full Text] [Related]
9. Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of Parkinson's disease.
Deng X; Liang Y; Lu H; Yang Z; Liu R; Wang J; Song X; Long J; Li Y; Lei D; Feng Z
PLoS One; 2013; 8(12):e80880. PubMed ID: 24312503
[TBL] [Abstract][Full Text] [Related]
10. Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease.
Gonzalez R; Garitaonandia I; Poustovoitov M; Abramihina T; McEntire C; Culp B; Attwood J; Noskov A; Christiansen-Weber T; Khater M; Mora-Castilla S; To C; Crain A; Sherman G; Semechkin A; Laurent LC; Elsworth JD; Sladek J; Snyder EY; Redmond DE; Kern RA
Cell Transplant; 2016 Nov; 25(11):1945-1966. PubMed ID: 27213850
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.
Choi DH; Kim JH; Kim SM; Kang K; Han DW; Lee J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117752
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.
Park S; Kim E; Koh SE; Maeng S; Lee WD; Lim J; Shim I; Lee YJ
Brain Res; 2012 Jul; 1466():158-66. PubMed ID: 22634376
[TBL] [Abstract][Full Text] [Related]
13. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
Jiang Z; Wang J; Sun G; Feng M
Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
[TBL] [Abstract][Full Text] [Related]
14. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
Stayte S; Rentsch P; Li KM; Vissel B
PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ
Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic neuroprotection by neurturin-expressing c17.2 neural stem cells in a rat model of Parkinson's disease.
Liu WG; Lu GQ; Li B; Chen SD
Parkinsonism Relat Disord; 2007 Mar; 13(2):77-88. PubMed ID: 16963309
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic differentiation of stem cells from human deciduous teeth and their therapeutic benefits for Parkinsonian rats.
Fujii H; Matsubara K; Sakai K; Ito M; Ohno K; Ueda M; Yamamoto A
Brain Res; 2015 Jul; 1613():59-72. PubMed ID: 25863132
[TBL] [Abstract][Full Text] [Related]
19. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
20. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
